Vertex, NICE, NHS miss Orkambi deadline

Although NHS England, NICE and Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) have complied with a Parliament committee's request and submitted documents regarding pricing negotiations over the biotech's cystic

Read the full 266 word article

User Sign In